Vitamin D and Type 2 Diabetes Mellitus
- Conditions
- Health Condition 1: E11- Type 2 diabetes mellitus
- Registration Number
- CTRI/2022/10/046633
- Lead Sponsor
- niversity College of Medical Sciences ang GTB Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Participants aged 18â??60 years
2.Participants who gave informed consent
3.Patient having FPG >=7.0 mmol/L (126 mg/dL), a glucose >=11.1 mmol/L (200 mg/dL) 2 h after an oral glucose challenge, or an HbA1c >=6.5%
1.Type 1 Diabetes Mellitus patient and Type 2 Diabetes Mellitus patient who is already on oral hypoglycemics or insulin.
2.An impaired renal function (estimated glomerular filtration rate <30 mL/min/1.73 m2, calculated from serum creatinine using the modification of renal disease formula)
3.Hypercalcemia (serum calcium >2.65 nmol/L).
4.The presence of severe anemia and iron deficiency anemia.
5.Chronic liver disease.
6.Alcoholism.
7.Pregnancy.
8.Any patient who is already on Vitamin D supplements.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change in serum HbA1c level between the Vitamin D plus standard drug group and the standard drug only group after 6 months of intervention.Timepoint: 6 months
- Secondary Outcome Measures
Name Time Method The change in insulin resistance level between the two groups.Timepoint: 6 months;The overall effect of Vitamin D supplementation on HbA1c in newly diagnosed Type 2 Diabetes Mellitus patients.Timepoint: 6 months;To know the status of Vitamin D in newly diagnosed Type 2 Diabetes Mellitus Patients.Timepoint: At beginning
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.